Related Experiment Video
Updated: Nov 8, 2025
Ex Vivo Pressurized Hippocampal Capillary-Parenchymal Arteriole Preparation for Functional Study
Published on: December 18, 2019
PIP2 corrects cerebral blood flow deficits in small vessel disease by rescuing capillary Kir2.1 activity
Fabrice Dabertrand1,2,3, Osama F Harraz4,5, Masayo Koide4,5
1Department of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405; fabrice.dabertrand@cuanschutz.edu Mark.Nelson@uvm.edu.
Insights
Small vessel diseases (SVDs) impair brain blood flow by reducing Kir2.1 channel activity. Restoring phosphatidylinositol 4,5-bisphosphate (PIP2) levels quickly recovered functional hyperemia in a mouse model.
Area of Science:
- Neuroscience
- Vascular Biology
- Cellular Physiology
Background:
- Cerebral small vessel diseases (SVDs) are linked to stroke and dementia, lacking specific treatments.
- Early SVD pathogenesis involves endothelial dysfunction and impaired functional hyperemia.
- Capillary endothelial Kir2.1 channels are crucial for sensing neuronal activity and regulating brain blood flow.
Purpose of the Study:
- Investigate the mechanisms underlying impaired functional hyperemia in SVDs.
- Determine the role of Kir2.1 channel activity in SVD pathogenesis.
- Explore potential therapeutic strategies for restoring functional hyperemia.
Main Methods:
- Utilized a genetic mouse model of SVD.
- Assessed functional hyperemia and Kir2.1 channel activity.
- Investigated the role of phosphatidylinositol 4,5-bisphosphate (PIP2) in Kir2.1 function.
- Administered soluble PIP2 to SVD mice.
Main Results:
- Impaired functional hyperemia in SVD mice was linked to diminished Kir2.1 channel activity.
- Kir2.1 deactivation resulted from depletion of PIP2, a key regulator of channel function.
- Systemic administration of soluble PIP2 rapidly restored functional hyperemia in SVD mice.
Conclusions:
- Reduced Kir2.1 channel activity due to PIP2 depletion is a key mechanism in SVD-related hyperemia deficits.
- Restoring PIP2 levels offers a potential therapeutic approach for SVDs and related neurological disorders.
Abstract:
Cerebral small vessel diseases (SVDs) are a central link between stroke and dementia-two comorbidities without specific treatments. Despite the emerging consensus that SVDs are initiated in the endothelium, the early mechanisms remain largely unknown. Deficits in on-demand delivery of blood to active brain regions (functional hyperemia) are early manifestations of the underlying pathogenesis. The capillary endothelial cell strong inward-rectifier K+ channel Kir2.1, which senses neuronal activity and initiates a propagating electrical signal that dilates upstream arterioles, is a cornerstone of functional hyperemia. Here, using a genetic SVD mouse model, we show that impaired functional hyperemia is caused by diminished Kir2.1 channel activity. We link Kir2.1 deactivation to depletion of phosphatidylinositol 4,5-bisphosphate (PIP2), a membrane phospholipid essential for Kir2.1 activity. Systemic injection of soluble PIP2 rapidly restored functional hyperemia in SVD mice, suggesting a possible strategy for rescuing functional hyperemia in brain disorders in which blood flow is disturbed.
More Related Videos
06:24Paired Cisterna Magna Nanoinjection and Laser Speckle Contrast Imaging Assay to Study Cerebral Blood Flow Regulation In Vivo
Published on: July 8, 2025
09:08In Vivo Fiber-Coupled Pre-Clinical Confocal Laser-scanning Endomicroscopy pCLE of Hippocampal Capillaries in Awake Mice
Published on: April 21, 2023